Personalis, Inc. is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Christopher Hall, with a market cap of $653.2M.
Common questions about Personalis, Inc.
Personalis, Inc. is scheduled to report earnings for Q1 2026 on May 5, 2026 after market close. Analysts estimate revenue of $14.5M.
Personalis, Inc. has approximately 225 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.